Y-Intercept (HK)’s AtriCure ATRC Stock Holding History

Y-Intercept (HK)’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,728	Closed	-$1.37M	–	1544
2025 Q4	$1.37M	Buy	34,728 +27,211	+362%	+$998K	0.03%	814
2025 Q3	$265K	Buy	+7,517	New	+$259K	0.01%	1415
2025 Q1	–	Sell	-14,997	Closed	-$458K	–	1189
2024 Q4	$458K	Sell	14,997 -6,887	-31%	-$221K	0.03%	770
2024 Q3	$614K	Buy	+21,884	New	+$539K	0.04%	673
2024 Q1	–	Sell	-11,078	Closed	-$395K	–	1358
2023 Q4	$395K	Buy	+11,078	New	+$412K	0.04%	712
2023 Q3	–	Sell	-6,019	Closed	-$297K	–	1056
2023 Q2	$297K	Buy	+6,019	New	+$277K	0.03%	772

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s ATRC Position: Q1 2026 in Review

Y-Intercept (HK) sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 34,728 shares — an estimated $1.37M sold.

Y-Intercept (HK) first reported a position in ATRC in Q2 2023 and held it in 6 quarters. The position peaked at $1.37M in Q4 2025. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

Y-Intercept (HK) reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
Y-Intercept (HK) sold 34,728 AtriCure shares in Q1 2026, an estimated $1.37M.
Y-Intercept (HK) first reported a position in AtriCure in Q2 2023 and held it in 6 quarters.
Y-Intercept (HK)'s AtriCure position peaked at $1.37M in Q4 2025.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.